# Yann Chong Tan

> Yann Chong Tan is a Singapore-based scientist and entrepreneur, co-founder and advisor at Nuevocor and its former CEO. He co-founded Atreca from work developed during his Stanford doctorate, served as chief technologist there, and later became chief innovation officer at A*STAR’s Genome Institute of Singapore. His career connects academic invention, commercialization and international company building.

- **Role:** Co-Founder and Advisor at Nuevocor
- **Organizations:** Nuevocor, Atreca, A*STAR Genome Institute of Singapore, Cargene Biopharma
- **Education:** BS in Biology, Duke University, PhD in Immunology, Stanford University
- **Known for:** Recipient of A*STAR National Science Scholarship undergraduate and doctoral fellowships., Co-developed technology underlying Atreca’s Immune Repertoire Capture platform during dissertation research., Named inventor with William H. Robinson and Jeremy Sokolove on the patent application Identification of polynucleotides associated with a sample.

## Career timeline

- **2008–2012** — Doctoral study at Stanford; developed technology underlying Atreca’s platform in William Robinson’s laboratory.
- **2012** — Co-founded Atreca; subsequently served as chief technologist.
- **2016** — Scheduled to deliver an Atreca case study at a Singapore workshop about pitching to biotech investors.
- **Before Nuevocor** — Chief Innovation Officer at A*STAR’s Genome Institute of Singapore, initiating and leading programs that produced spin-offs.
- **2020** — Nuevocor spun out from A*STAR; Tan was a co-founder and founding CEO.
- **2021** — Nuevocor raised a US$24 million Series A.
- **2022** — Identified as Cargene co-founder in its announcement appointing Kathy He CEO.
- **2025** — Led Nuevocor during its announced US$45 million Series B.
- **2026** — Publicly welcomed Al Gianchetti as Nuevocor CEO; company now lists Tan as co-founder and advisor.

## Achievements

- Recipient of A*STAR National Science Scholarship undergraduate and doctoral fellowships.
- Co-developed technology underlying Atreca’s Immune Repertoire Capture platform during dissertation research.
- Named inventor with William H. Robinson and Jeremy Sokolove on the patent application Identification of polynucleotides associated with a sample.
- Co-founded Atreca, Nuevocor and Cargene.
- Helped build Nuevocor through its announced US$24 million Series A and US$45 million Series B.

## Latest updates

- **2026-01** — Welcomed Al Gianchetti’s appointment as Nuevocor CEO and described plans for further science venture projects.
- **2025-05** — Nuevocor announced a US$45 million Series B while Tan served as CEO, alongside plans for a Paris office.

## Links

- Website: https://www.nuevocor.com/
- LinkedIn: https://www.linkedin.com/in/yann-chong-tan/

---

Profile page: https://yespress.io/yann-chong-tan
Published by YesPress — https://yespress.io
Last updated: 2026-10-14